Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells is a research paper published in PLoS Genetics (2020). On theSindex it has a DataRank of 0.655. It has been cited 78 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.655
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA245548
NCI NIH HHS
Grant: R01 CA197796
NIGMS NIH HHS
Grant: R01 GM125812
NIH HHS
Grant: S10 OD021684
National Institutes of Health
Grant: 5R01CA245548-02
The kynurenine-AHR pathway in biomass production
National Institutes of Health
Grant: 1S10OD021684-01
Laser Scanning Confocal for UT Southwestern Live Cell Imaging Facility
National Institutes of Health
Grant: 7R01CA197796-05
Mechanisms of EXO1 regulation in response to radiation-induced DNA damage
National Institutes of Health
Grant: 1R01GM125812-01
Regulation of mRNA translation during germline cyst differentiation
FWCI
3.13
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death
Additional file 2 of BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death